株式会社トランスジェニックグループ 神戸研究所閉鎖のお知らせ

This document announces the decision by Transgenic Group Inc. to close its Kobe Research Institute. Established in 2005, the institute has been involved in gene-modified mouse and large animal pharmacology businesses. However, due to the ongoing downturn in the life sciences research market and a decrease in public research funding, the business environment has become challenging. Consequently, the functions of the institute will be transferred to the Iwata Research Institute and Kurume Modality Analysis Center, with a shift in the business model. The closure is scheduled for December 2026, and it is expected to result in an annual fixed cost reduction of approximately 100 million yen.